Watch Ticker

Opus Genetics, Inc. Common Stock

Go to Opus Genetics, Inc. Common Stock Website

$1.11

0.00 (-0.42%)

Live

Previous Close

$1.11

Day Range

$1.08 - $1.13

Previous Day Range

$1.06 - $1.1362

Market Cap

$64.4 million USD

Day Vol.

55408

Previous Day Vol.

76969

Currency

USD

Primary Exchange

None

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Opus Genetics Announces LYNX-2 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients with Visual Disturbances Under Mesopic, Low-Contrast Conditions

Opus Genetics announced positive results from its LYNX-2 Phase 3 trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating vision disturbances in keratorefractive patients. The study met its primary endpoint, showing a significant improvement in mesopic low contrast distance visual acuity compared to placebo.

Related tickers: IRD, VTRS.

Read Full Article

Professor Ari Zoldan - Top 10 Small-Cap Stocks to Watch in 2025

The article discusses 10 small-cap stocks that could outperform in 2025, citing factors like falling interest rates, low valuations, and potential shifts in industrial production.

Related tickers: AUNA, CNTX, EVGO, EVGOW, FFIC, CRGO, CRGOW, IKT, OKLO, IRD, PENG, WOLF.

Read Full Article

Trending Tickers

Please sign in to view